Loading organizations...
Key people at Octave Group.
Octave Specialty Group operates as a global managing general agent (MGA) platform, delivering innovative specialty insurance products. It integrates strategic direction, comprehensive risk oversight, and advanced data and artificial intelligence technologies to enhance underwriting capabilities and streamline market efficiency.
The company’s current form evolved from Ambac, a financial services entity, rebranding to emphasize its strategic focus on specialty insurance. Claude LeBlanc, President and Chief Executive Officer, guides this transition, driven by the insight into the insurance market's growing need for specialized and technologically advanced solutions.
Octave Specialty Group serves various entities within the insurance ecosystem, providing sophisticated underwriting and distribution services. Its vision is to become the leading global MGA platform, continuously innovating and leveraging technology to offer customized insurance products and shape the future of the specialty insurance landscape.
Octave Group has 1 tracked investment across 1 company. The latest tracked deal is $90.0M Series D in Finch Therapeutics in September 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 17, 2020 | Finch Therapeutics | $90.0M Series D | — | Avenir, Baupost Group, Humboldt Fund, MSD Capital, MSD Partners, OCV Partners, Nick Haft, Shumway Capital, SIG, SymBiosis, Trans Pacific Technology Fund, Willett Advisors |
Key people at Octave Group.